Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The new Oxford Lymphoid Disorder Study Group, chaired by Dr Graham Collins, will be launched this September in Blood Cancer Awareness Month

The Oxford Lymphoid Disorder Study Group (OLDSG) will be introduced later this month at a virtual launch event being held on Friday 18 September 2020, 2 – 5 pm.

The group is led by Dr Graham Collins and a steering group, who will be helping to translate and direct lymphoid research in Oxford into patient-focused applications.

The upcoming event on 18 September 2020 falls within Blood Cancer Awareness Month in the UK, and will give those involved in various lymphoid disorder research the opportunity to talk more about their work and how it applies to diseases such as Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia.

You can sign up for this upcoming event and see the full agenda of talks from top clinicians and researchers in the lymphoid disorder sector, by clicking here.

About the OLDSG

At present, around 3-4% of people will develop either lymphoma or Chronic Lymphocytic Leukemia (CLL) during their lifetime. Together, lymphoma and CLL represent the commonest blood cancer by some margin.

The OLDSG acts as a network to bring together researchers and clinicians from across the University of Oxford and University Hospitals Trust. In doing so, the group hopes to:

  • to increase the visibility of lymphoid disorder research in the university
  • to foster collaborations between clinicians and laboratory-based scientists leading to high quality translational projects
  • to interact with patients and the public at all levels of project development to deliver research which impacts directly on patient need

For more information about the group and its members, please see the dedicated OLDSG page here.

Similar Stories

World Chronic Lymphoid Leukaemia Day 2021

Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.

The next step in personalised cancer medicine

Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.

Oxford Cancer welcomes Professor Stefan Constantinescu

Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.